Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Departing Words: Merck’s Ken Frazier Cautions Against Profit Maximization

Nov 21 2022

• By Sarah Karlin-Smith

Kenneth Frazier, Chairman of the Board and CEO of US pharmaceutical company Merck looks on during an event with the French-American Foundation in Paris on July 11, 2018. (Photo by ERIC PIERMONT / AFP) GettyImages-996036844 — • Source: Eric Piermont/AFP via Getty Images

Related Content

Merck’s Frazier Urges Businesses To Use ‘Every Instrument At Their Disposal’ To Reduce Racial Inequity

Jun 03 2020

Cancer Drugs And Medicare: Range Of Impacts Expected From IRA Price Reforms

Nov 09 2022

Industry In The Middle: Merck's Frazier Takes A Stand, Trump Tweets Back

Aug 14 2017

Related Companies

Merck & Co., Inc.

Additional Topics

United States Leadership Pricing Debate Politics Business Strategies Pricing Strategies Commercial Policy BioPharmaceutical

More from Leadership

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window